Novartis India - Results Press Release
Novartis India Ltd has informed BSE regarding a Press Release titled "Novartis India Announces Improved Results for the Quarter and Half-Year ended 30 September 2009".29-10-2009
Novartis India - Results Press Release
Novartis India Ltd has informed BSE regarding a Press Release titled "Novartis India Announces Improved Results for the Quarter and Half-Year ended 30 September 2009".Novartis India - Financial Results for Sep 30, 2009
Novartis India Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2009.Novartis India - Updates on Outcome of AGM
Novartis India Ltd has submitted to BSE a copy of the Minutes of the 61st Annual General Meeting (AGM) of the Company held on July 17, 2009.Novartis India - Outcome of AGM
Novartis India Ltd has informed BSE that the shareholders at the Annual General Meeting (AGM) of the Company held on July 17, 2009, inter alia, have approved the following:1. Approved the Accounts for the year ended March 31, 2009.2. Dividend @ 200% (Rs 10/- per equity share of Rs 5 each).3. Re-appointment of Messrs. Price Waterhouse, Chartered Accountant as Auditors.4. Re-election of Mr. Ranjit Shahani to the Board of Directors.Novartis India - Results Press Release
Novartis India Ltd has informed BSE regarding a Press Release dated July 16, 2009 titled "Novartis India Announces Results for 1st Quarter ended June 30, 2009"Novartis India - Financial Results for Jun 30, 2009
Novartis India Ltd has informed BSE about the financial results for the Quarter ended June 30, 2009.Novartis India - AGM on Jul 17, 2009
Novartis India Ltd has informed BSE that the 61st Annual General Meeting (AGM) of the members of the Company will be held on July 17, 2009.Novartis India - Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Novartis India Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:Novartis India - Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Novartis India Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:Novartis India - Post Offer Status
DSP Merrill Lynch Ltd ("Manager to the Offer") for & on behalf of Novartis AG ("Acquirer") has issued this Post Offer Public Announcement to the shareholders of Novartis India Ltd ("Target Company"), which is in continuation of and should be read in conjunction with the Letter of Offer dated May 14, 2009 ("Letter of Offer") and the Supplemental Public Announcement ("PA") dated May 27, 2009, pursuant to Regulation 11(1) of, and in compliance with,...